Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

May 10, 2019

Study Completion Date

May 18, 2019

Conditions
Nalbuphine,Fentanyl and Local Anesthetic Mixture
Interventions
DRUG

Nalbuphine Group

"All patients received 8 ml of LAM which consisted of: 6 ml of ml of bupivacaine 0.5%, 1 ml of hyaluronidase containing 150 IU, 1 ml of additive~Patients were categorized into three groups according to the type of additive used with the LAM as follows:~Group N:(Nalbuphine group)1 ml saline containing 4mg nalbuphine used instead of normal saline"

DRUG

Fentanyl Group

"All patients received 8 ml of LAM which consisted of: 6 ml of ml of bupivacaine 0.5%, 1 ml of hyaluronidase containing 150 IU, 1 ml of additive~Patients were categorized into three groups according to the type of additive used with the LAM as follows:~Group F: :(Fentanyl group)1 ml saline containing 20 μg fentanyl used instead of normal saline"

DRUG

Control Group

"All patients received 8 ml of LAM which consisted of: 6 ml of ml of bupivacaine 0.5%, 1 ml of hyaluronidase containing 150 IU, 1 ml of additive~Patients were categorized into three groups according to the type of additive used with the LAM as follows:~Group C (Control group): included patients assigned to receive 1 ml normal saline."

Trial Locations (1)

11451

Ahmed Abdalla Mohamed, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03824665 - Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture | Biotech Hunter | Biotech Hunter